Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: Importance of hormone replacement therapy use

European Journal of Clinical Nutrition

Volumn 63, Issue 12, 2009, Pages 1419-1424

  Arsenault, B J ^a,b   Earnest, C P ^c   Despres J P ^a,b   Blair, S N ^d   Church, T S ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Coffee; CRP; Hormone replacement therapy; Obesity; Postmenopausal women

Indexed keywords

C REACTIVE PROTEIN; HORMONE;

ADULT; ARTICLE; BODY MASS; COFFEE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; PROTEIN BLOOD LEVEL;

EID: 75049084220     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2009.112     Document Type: Article

References (24)

1. Andersen LF, Jacobs Jr DR, Carlsen MH, Blomhoff R (2006). Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 83, 1039-1046.
2. Brett KM, Chong Y (2001). Hormone Replacement Therapy: Knowledge and Use in the United States. National Center for Health Statistics: Hyattsville, MD.
3. Buchbinder S, Kratzsch J, Fiedler GM, Yar V, Brugel M, Leichtle A et al. (2008). Body weight and oral contraceptives are the most important modulators of serum CRP levels. Scand J Clin Lab Invest 68, 140-144.
4. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G et al. (2004). Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18, 1670-1681.
5. Church TS, Earnest CP, Skinner JS, Blair SN (2007). Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297, 2081-2091.
6. Cooper BC, Burger NZ, Toth MJ, Cushman M, Sites CK (2007). Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol 196, 123.e121-127.
7. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387-1397.
8. Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, Witteman JC (2007). Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 30, 2695-2699.
9. Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E et al. (2008). Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122, 2071-2076.
10. Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T et al. (2008). The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 46, 1434-1437.
11. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N (1998). Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 35 (Part 6), 745-753.
12. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A et al. (2001). Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21, 961-967.
13. Lopez-Garcia E, van Dam RM, Qi L, Hu FB (2006). Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84, 888-893.
14. Morss GM, Jordan AN, Skinner JS, Dunn AL, Church TS, Earnest CP et al. (2004). Dose response to exercise in women aged 45-75 yr (DREW): design and rationale. Med Sci Sports Exerc 36, 336-344.
15. Nakamura H, Ito H, Egami Y, Kaji Y, Maruyama T, Koike G et al. (2008). Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract 79, 330-336.
16. Nanri A, Moore MA, Kono S (2007). Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8, 167-177.
17. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE (1999). Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100, 713-716. (Pubitemid 29383640)
18. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ et al. (2004). Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140, 1-8.
19. Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA et al. (2003). Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 107, 3165-3169.
20. Storey ML, Forshee RA, Anderson PA (2006). Beverage consumption in the US population. J Am Diet Assoc 106, 1992-2000.
21. University of Texas H (1996). Food Intake Analysis System (computer program) Version 3.0. University of Texas Press: Austin.
22. van Dam RM, Feskens EJ (2002). Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360, 1477-1478.
23. van Dam RM, Hu FB (2005). Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294, 97-104.
24. Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C (2004). Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80, 862-867.